Tag: Amy J. Wagers

  • Health

    Blood tells old cells to act young

    Harvard Stem Cell Institute (HSCI) researchers at the Joslin Diabetes Center (JDC) have taken a major step toward eventually understanding — and perhaps slowing — the aging process. In a series of careful experiments, Amy J. Wagers and colleagues have demonstrated that the stem cells of old mice exposed to certain factors present in blood from young mice…

    3–4 minutes
  • Health

    Three Harvard teams to receive $9 million each in federal funding for stem cell research

    Three teams of Harvard Stem Cell Institute (HSCI) researchers are slated to receive $27 million over seven years in National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders.  The NHLBI Progenitor Cell Biology Consortium will consist of nine research…

    3–4 minutes
  • Science & Tech

    Five at Harvard named HHMI Early Career Scientists;

    Five Harvard scientists are among 50 young scientists  nationwide who will have their work supported for the next six years by a new initiative from the Howard Hughes Medical Institute (HHMI). HHMI today announced that the selected scientists are at 33 institutions across the United States and have led their own laboratories for two to…

    5–8 minutes
  • Health

    NIH names Harvard Pioneers, Innovators

    Harvard faculty members comprise almost 20 percent of the 47 scientists nationally whose promising and innovative work was today recognized with the announcement of two grant programs through the National Institutes of Health (NIH). The grants, expected to total $138 million over five years for all recipients, recognize established researchers through the Pioneer Award and…

    4–7 minutes
  • Health

    GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement

    GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases. GSK’s investment, one of the largest by a pharmaceutical company in…

    3–4 minutes
  • Health

    Amy Wagers – focusing on stem cell biology

    Twenty minutes after her weekly lab meeting is scheduled to begin, Amy Wagers rushes into a conference room on the fourth floor of the Joslin Diabetes Center, where her lab team sits, chatting around a long oval table. “Sorry I’m late,” she calls out, closing the door behind her. “Oh good, the food’s here!” Grabbing…

    6–9 minutes
  • Health

    Stem cells used to treat muscular dystrophy in mice

    Harvard Stem Cell Institute researchers at the Joslin Diabetes Center have for the first time demonstrated that transplanted muscle stem cells can both improve muscle function in mice with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries. “I’m very excited about this,” said…

    3–4 minutes